✦ LIBER ✦

Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer

✍ Scribed by Keun Seok Lee; Hyun Cheol Chung; Seock Ah Im; Yeon Hee Park; Chul Soo Kim; Sung-Bae Kim; Sun Young Rha; Min Young Lee; Jungsil Ro

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Paclitaxel and carboplatin in patients w

✍ Zielinski, CC; Schnack, B; Grbovic, M; Brodowicz, T; Wiltschke, C; Steger, G; Pf 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 755 KB

A phase II trial of imatinib mesylate mo

✍ Shanu Modi; Andrew D. Seidman; Maura Dickler; Mark Moasser; Gabriella D’Andrea; 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 255 KB

Multicenter randomized phase III trial o

✍ Baldini, E; Prochilo, T; Salvadori, B; Bolognesi, A; Aldrighetti, D; Venturini, 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 101 KB

Primary chemotherapy with doxorubicin an

✍ P. Schmid; J. Krocker; G. Morack; V. Heilmann; J.-U. Blohmer; K. Michniewicz; G. 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 198 KB

A phase II trial of docetaxel (Taxotere®

✍ Martina Baur; Allan T. van Oosterom; Véronique Diéras; Michele Tubiana-Hulin; R. 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 385 KB

Results of a phase II open-label, nonran

✍ John W. Smith; Kristi J. McIntyre; Patrick V. Acevedo; Carlos A. Encarnacion; Ka 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 230 KB